vs
PLUMAS BANCORP（PLBC）与ARS Pharmaceuticals, Inc.（SPRY）财务数据对比。点击上方公司名可切换其他公司
PLUMAS BANCORP的季度营收约是ARS Pharmaceuticals, Inc.的1.0倍（$28.6M vs $28.1M），PLUMAS BANCORP同比增速更快（35.1% vs -67.6%）
Plumas Bancorp是一家美国银行控股公司，通过旗下子公司Plumas Bank开展业务，为加利福尼亚州北部及内华达州的个人客户、中小企业和本地社区机构提供存款、各类贷款、财富管理等综合零售及商业银行服务。
ARS Pharmaceuticals是一家处于后期研发阶段的生物制药企业，专注于开发和商业化严重过敏反应创新疗法，核心产品为无需注射的肾上腺素鼻腔递送制剂，主要面向北美市场，服务存在致命过敏风险的成人及儿童患者群体。
PLBC vs SPRY — 直观对比
营收规模更大
PLBC
是对方的1.0倍
$28.1M
营收增速更快
PLBC
高出102.6%
-67.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $28.6M | $28.1M |
| 净利润 | — | $-41.3M |
| 毛利率 | — | — |
| 营业利润率 | 48.9% | -147.6% |
| 净利率 | — | -147.1% |
| 营收同比 | 35.1% | -67.6% |
| 净利润同比 | — | -182.8% |
| 每股收益（稀释后） | $1.56 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLBCSPRY
| Q4 25 | $28.6M | $28.1M | ||
| Q3 25 | $27.4M | $32.5M | ||
| Q2 25 | $20.5M | $15.7M | ||
| Q1 25 | $21.8M | $8.0M | ||
| Q4 24 | $21.2M | $86.6M | ||
| Q3 24 | $21.1M | $2.1M | ||
| Q2 24 | $20.6M | $500.0K | ||
| Q1 24 | $19.6M | $0 |
净利润PLBCSPRY
| Q4 25 | — | $-41.3M | ||
| Q3 25 | $5.1M | $-51.2M | ||
| Q2 25 | $6.3M | $-44.9M | ||
| Q1 25 | $7.2M | $-33.9M | ||
| Q4 24 | — | $49.9M | ||
| Q3 24 | $7.8M | $-19.1M | ||
| Q2 24 | $6.8M | $-12.5M | ||
| Q1 24 | $6.3M | $-10.3M |
营业利润率PLBCSPRY
| Q4 25 | 48.9% | -147.6% | ||
| Q3 25 | 25.2% | -163.7% | ||
| Q2 25 | 42.2% | -302.9% | ||
| Q1 25 | 46.1% | -466.3% | ||
| Q4 24 | 50.3% | 54.5% | ||
| Q3 24 | 50.6% | -1051.6% | ||
| Q2 24 | 45.1% | -3068.0% | ||
| Q1 24 | 42.8% | — |
净利率PLBCSPRY
| Q4 25 | — | -147.1% | ||
| Q3 25 | 18.8% | -157.4% | ||
| Q2 25 | 30.8% | -285.6% | ||
| Q1 25 | 33.0% | -425.7% | ||
| Q4 24 | — | 57.7% | ||
| Q3 24 | 37.1% | -925.0% | ||
| Q2 24 | 32.9% | -2503.2% | ||
| Q1 24 | 31.9% | — |
每股收益（稀释后）PLBCSPRY
| Q4 25 | $1.56 | $-0.41 | ||
| Q3 25 | $0.73 | $-0.52 | ||
| Q2 25 | $1.05 | $-0.46 | ||
| Q1 25 | $1.20 | $-0.35 | ||
| Q4 24 | $1.30 | $0.52 | ||
| Q3 24 | $1.31 | $-0.20 | ||
| Q2 24 | $1.14 | $-0.13 | ||
| Q1 24 | $1.05 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.6M | $245.0M |
| 总债务越低越好 | — | $96.4M |
| 股东权益账面价值 | $261.1M | $114.3M |
| 总资产 | $2.2B | $327.7M |
| 负债/权益比越低杠杆越低 | — | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资PLBCSPRY
| Q4 25 | $80.6M | $245.0M | ||
| Q3 25 | $87.3M | $288.2M | ||
| Q2 25 | $79.3M | $240.1M | ||
| Q1 25 | $87.3M | $275.7M | ||
| Q4 24 | $82.0M | $314.0M | ||
| Q3 24 | $118.0M | $204.6M | ||
| Q2 24 | $109.9M | $218.7M | ||
| Q1 24 | $128.2M | $223.6M |
总债务PLBCSPRY
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PLBCSPRY
| Q4 25 | $261.1M | $114.3M | ||
| Q3 25 | $245.9M | $147.7M | ||
| Q2 25 | $193.1M | $192.3M | ||
| Q1 25 | $187.6M | $229.0M | ||
| Q4 24 | $177.9M | $256.8M | ||
| Q3 24 | $181.9M | $201.0M | ||
| Q2 24 | $165.2M | $215.2M | ||
| Q1 24 | $161.5M | $223.9M |
总资产PLBCSPRY
| Q4 25 | $2.2B | $327.7M | ||
| Q3 25 | $2.2B | $372.8M | ||
| Q2 25 | $1.6B | $313.5M | ||
| Q1 25 | $1.6B | $327.3M | ||
| Q4 24 | $1.6B | $351.2M | ||
| Q3 24 | $1.7B | $217.6M | ||
| Q2 24 | $1.6B | $222.0M | ||
| Q1 24 | $1.6B | $227.6M |
负债/权益比PLBCSPRY
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.6M | $-43.5M |
| 自由现金流经营现金流 - 资本支出 | $20.3M | — |
| 自由现金流率自由现金流/营收 | 70.9% | — |
| 资本支出强度资本支出/营收 | 4.6% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $34.4M | — |
8季度趋势，按日历期对齐
经营现金流PLBCSPRY
| Q4 25 | $21.6M | $-43.5M | ||
| Q3 25 | $5.6M | $-47.0M | ||
| Q2 25 | $2.1M | $-39.6M | ||
| Q1 25 | $7.5M | $-40.7M | ||
| Q4 24 | $30.5M | $42.0M | ||
| Q3 24 | $8.0M | $-14.5M | ||
| Q2 24 | $5.1M | $-7.3M | ||
| Q1 24 | $9.2M | $-6.7M |
自由现金流PLBCSPRY
| Q4 25 | $20.3M | — | ||
| Q3 25 | $4.8M | $-47.2M | ||
| Q2 25 | $2.0M | $-39.6M | ||
| Q1 25 | $7.3M | $-40.8M | ||
| Q4 24 | $29.8M | $41.7M | ||
| Q3 24 | $7.8M | $-14.6M | ||
| Q2 24 | $4.8M | $-7.3M | ||
| Q1 24 | $9.0M | $-6.8M |
自由现金流率PLBCSPRY
| Q4 25 | 70.9% | — | ||
| Q3 25 | 17.5% | -145.4% | ||
| Q2 25 | 9.9% | -252.2% | ||
| Q1 25 | 33.7% | -512.1% | ||
| Q4 24 | 141.0% | 48.2% | ||
| Q3 24 | 37.1% | -706.3% | ||
| Q2 24 | 23.5% | -1463.4% | ||
| Q1 24 | 45.8% | — |
资本支出强度PLBCSPRY
| Q4 25 | 4.6% | 0.0% | ||
| Q3 25 | 2.9% | 0.6% | ||
| Q2 25 | 0.2% | 0.3% | ||
| Q1 25 | 0.8% | 1.1% | ||
| Q4 24 | 3.2% | 0.3% | ||
| Q3 24 | 0.7% | 6.8% | ||
| Q2 24 | 1.1% | 7.6% | ||
| Q1 24 | 1.0% | — |
现金转化率PLBCSPRY
| Q4 25 | — | — | ||
| Q3 25 | 1.09× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 1.04× | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | 1.02× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.46× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLBC
暂无分部数据
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
